Thrivent Financial for Lutherans
HRMY icon

Thrivent Financial for Lutherans’s Harmony Biosciences HRMY Stock Holding History

Thrivent Financial for Lutherans’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$955K Sell
26,231
-295
-1% -$9.31K ﹤0.01% 2014
2026
Q1 		$743K Sell
26,526
-781
-3% -$25.6K ﹤0.01% 2049
2025
Q4 		$1.02M Sell
27,307
-1,332
-5% -$43.8K ﹤0.01% 1922
2025
Q3 		$789K Buy
28,639
+348
+1% +$12K ﹤0.01% 1907
2025
Q2 		$894K Buy
28,291
+224
+0.8% +$7.21K ﹤0.01% 1849
2025
Q1 		$932K Sell
28,067
-1,468
-5% -$52.6K ﹤0.01% 1761
2024
Q4 		$1.02M Buy
29,535
+5,880
+25% +$202K ﹤0.01% 1895
2024
Q3 		$946K Sell
23,655
-2,747
-10% -$96.5K ﹤0.01% 1947
2024
Q2 		$797K Sell
26,402
-2,053
-7% -$61.7K ﹤0.01% 1989
2024
Q1 		$956K Sell
28,455
-773
-3% -$24.8K ﹤0.01% 1921
2023
Q4 		$944K Sell
29,228
-1,509
-5% -$42.1K ﹤0.01% 1876
2023
Q3 		$1.01M Buy
30,737
+2,060
+7% +$71.5K ﹤0.01% 1736
2023
Q2 		$1.01M Sell
28,677
-715
-2% -$24.7K ﹤0.01% 1797
2023
Q1 		$960K Sell
29,392
-1,031
-3% -$47K ﹤0.01% 1811
2022
Q4 		$1.68M Sell
30,423
-155
-0.5% -$8.52K ﹤0.01% 1371
2022
Q3 		$1.35M Buy
30,578
+7,953
+35% +$388K ﹤0.01% 1481
2022
Q2 		$1.1M Buy
22,625
+4,061
+22% +$183K ﹤0.01% 1656
2022
Q1 		$903K Buy
18,564
+6
+0% +$245 ﹤0.01% 1887
2021
Q4 		$791K Buy
+18,558
New +$740K ﹤0.01% 1986

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Thrivent Financial for Lutherans's HRMY Position: Q2 2026 in Review

Thrivent Financial for Lutherans reduced its Harmony Biosciences (HRMY) stake by 1.1% in Q2 2026, selling an estimated $9.31K and leaving 26,231 shares worth $955K. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

Thrivent Financial for Lutherans first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.68M in Q4 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Thrivent Financial for Lutherans held 26,231 shares of Harmony Biosciences worth $955K as of Q2 2026.
  • Thrivent Financial for Lutherans sold 295 Harmony Biosciences shares in Q2 2026, an estimated $9.31K.
  • Harmony Biosciences made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #2014 holding.
  • Thrivent Financial for Lutherans first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Thrivent Financial for Lutherans's Harmony Biosciences position peaked at $1.68M in Q4 2022.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.